RIGEL PHARMACEUTICALS INC (RIGL)
US7665597024 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 51.69M | 32.79M | 24.50M | 18.90M | 30.40M | |||
| Marketable Securities | 9.42M | 24.15M | 33.70M | 106.10M | 27.00M | |||
| Receivables | 30.57M | 30.55M | 40.30M | 15.50M | 16.00M | |||
| Inventories | 4.78M | 5.52M | 9.10M | 6.60M | 1.60M | |||
| Other Current Assets | 9.99M | 6.26M | 8.30M | 7.40M | 14.00M | |||
| Total Current Assets | 106.47M | 99.27M | 115.90M | 154.50M | 89.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 504.00K | 1.03M | 2.80M | 11.90M | 20.60M | |||
| Intangibles | 27.69M | 13.88M | 14.90M | N/A | N/A | |||
| Other Non-Current Assets | 4.76M | 3.06M | 600.00K | 1.00M | 800.00K | |||
| Total Non-Current Assets | 32.95M | 17.96M | 18.40M | 12.80M | 21.40M | |||
| TOTAL ASSETS | 139.42M | 117.22M | 134.30M | 167.30M | 110.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 7.23M | N/A | N/A | N/A | |||
| Accrued Expenses | 21.95M | 18.21M | 24.20M | 43.70M | 34.10M | |||
| Accounts Payable | 3.81M | 7.14M | 22.50M | 3.80M | 3.70M | |||
| Other Current Liabilities | 28.55M | 20.68M | 18.50M | 16.10M | 3.00M | |||
| Total Current Liabilities | 54.31M | 53.27M | 65.20M | 63.60M | 40.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 59.76M | 52.37M | 39.40M | 19.90M | 19.80M | |||
| Other Non-Current Liabilities | 39.98M | 40.23M | 43.20M | 53.50M | 15.70M | |||
| Total Non-Current Liabilities | 99.74M | 92.60M | 82.70M | 73.40M | 35.60M | |||
| TOTAL LIABILITIES | 154.06M | 145.87M | 147.90M | 137.00M | 76.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.40B | -1.41B | -1.38B | -1.32B | -1.31B | |||
| Additional Paid In Capital | 1.39B | 1.38B | 1.37B | 1.35B | 1.34B | |||
| Common Shares | 17.00K | 175.00K | 200.00K | 200.00K | 200.00K | |||
| Other Shareholders' Equity | 11.00K | 8.00K | -200.00K | -100.00K | 0.00 | |||
| Shares Outstanding | 17.61M | 17.48M | 173.40M | 171.60M | 169.30M | |||
| Tangible Book Value per Share | -2.40 | -2.43 | -0.16 | 0.18 | 0.20 | |||
| Total Shareholders' Equity | -14.64M | -28.64M | -13.60M | 30.40M | 34.00M | |||
| TOTAL LIABILITIES AND EQUITY | 139.42M | 117.22M | 134.30M | 167.30M | 110.40M | |||
| Statistics | ||||||||
| Debt/Equity | -4.08 | -1.83 | -2.90 | 0.65 | 0.58 | |||
| Current Ratio | 1.96 | 1.86 | 1.78 | 2.43 | 2.18 | |||
| Return On Assets (ROA) | 2.78% | -21.40% | -43.63% | -10.70% | -26.90% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -58.88% | -87.35% | |||
| Return On Invested Capital (ROIC) | 8.82% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 31.29% | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21